Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2019-01-02 2018-08-27
Drug Identification Number 02375710 02375710
Brand name DOXORUBICIN HYDROCHLORIDE INJECTION DOXORUBICIN HYDROCHLORIDE INJECTION
Common or Proper name DOXORUBICIN DOXORUBICIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients DOXORUBICIN HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVESICAL INTRAVENOUS INTRAVESICAL
Packaging size 25ML VIAL 25ML VIAL
ATC code L01DB L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date
Actual discontinuation date 2019-01-01 2019-01-01
Remaining supply date 2019-01-01 2019-01-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments